In the vast realm of biotechnology and pharmaceuticals, microorganisms are the unsung heroes — the living engines behind everything from antibiotics and enzymes to vaccines and biologics. These minuscule life forms have been foundational to scientific breakthroughs for over a century, yet with the advent of synthetic biology, bioprocessing, and bioinformatics, their utility is undergoing […]
Tag: Pichia pastoris
Beyond E. coli: Evolving CDMO Microbial Mastery
In today’s biopharma landscape, microbial versatility isn’t a luxury—it’s a necessity. For decades, Escherichia coli has been the microbial workhorse of the CDMO world, offering fast growth, simple genetics, and ease of scale-up. But the biologics being made today—complex enzymes, glycosylated proteins, biosimilars, and new modalities—are pushing the limits of what E. coli can deliver. […]
